🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Shandong University clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Shandong University as lead sponsor. Synced 26 Sep 2026
27Current trials
16Recruiting now
25Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Shandong University is the lead sponsor of 27 current clinical trials in our China register. 16 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Dexamethasone, Afatinib and Amoxicillin. The most-studied condition is Robot Surgery.

ClinicalTrials.gov trials by status

  • Recruiting1659%
  • Not yet open830%
  • Active, closed311%

Trials by phase

  • Not applicable933%
  • Observational830%
  • Phase 2415%
  • Phase 4311%
  • Phase 2/314%
  • Phase EARLY_PHASE114%
  • Phase 314%
01

Clinical trials sponsored by Shandong University

27 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Model-informed Individualized Treatment of Anti-infective Drugs
NCT06711562 · ClinicalTrials.gov ↗ · Osteoarticular Infections
Observational Recruiting 2024-10 China
Population Pharmacokinetics of Terbinafine in Children With Tinea Capitis
NCT07046988 · ClinicalTrials.gov ↗ · Tinea Capitis
Observational Recruiting 2021-06 China
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations
NCT06076200 · ClinicalTrials.gov ↗ · Early-Onset Neonatal Sepsis
Observational Recruiting 2023-09 China
Effect of Predictive Model on Double-Balloon Enteroscopy
NCT07288346 · ClinicalTrials.gov ↗ · Double-balloon Enteroscopy
Not applicable Recruiting 2026-01 China
Antineoplastic Drugs in Elderly Patients
NCT05467189 · ClinicalTrials.gov ↗ · Cancer
Observational Recruiting 2021-01 China
Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections
NCT06711575 · ClinicalTrials.gov ↗ · Infectious Diseases of Spine
Observational Recruiting 2024-10 China
Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication
NCT06723197 · ClinicalTrials.gov ↗ · HELICOBACTER PYLORI INFECTIONS
Phase 4 Recruiting 2024-12 China
Corona Virus Disease 2019 Cohort Study
NCT06927622 · ClinicalTrials.gov ↗ · COVID-19 Pneumonia, COVID-19 Pandemic, COVID-19
Observational Recruiting 2023-04 China
Linked-Color Imaging Versus Indigo Carmine Pump Spraying on the Colorectal Adenoma Detection Rate
NCT06961149 · ClinicalTrials.gov ↗ · Colonic Polyps, Adenomatous Polyps, Adenoma Detection Rate
Not applicable Recruiting 2025-04 China
Active Locomotion of Magnetically Controlled Capsule Endoscopy in the Small Bowel: A Feasibility Study
NCT07325344 · ClinicalTrials.gov ↗ · Capsule Endoscopy
Not applicable Recruiting 2025-12 China
A Study on the Infusion Regimen of Piperacillin-Tazobactam in Patients Aged 65 and Older With Pneumonia
NCT06972537 · ClinicalTrials.gov ↗ · Pneumonia
Not applicable Recruiting 2024-07 China
Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
NCT06251947 · ClinicalTrials.gov ↗ · Ovarian Cancer, Cervical Cancer
Phase 2 Recruiting 2024-04 China
Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer
NCT06748352 · ClinicalTrials.gov ↗ · Early Gastric Cancer, Endoscopic Submucosal Dissection, Robot Surgery
Not applicable Recruiting 2024-12 China
Effect of Metformin on Healthy Live Birth in Women With Prediabetes
NCT06064669 · ClinicalTrials.gov ↗ · Metformin, Prediabetes, In-Vitro Fertilization
Not applicable Recruiting 2024-02 China
Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma
NCT04716686 · ClinicalTrials.gov ↗ · Endometrial Carcinoma, Serous Carcinoma
Drug: Niraparib
Phase 2 Recruiting 2021-06 China
High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia
NCT07559331 · ClinicalTrials.gov ↗ · Primary Immune Thrombocytopenia (ITP)
Phase 3 Recruiting 2026-04 China
Efficacy and Safety of Robot-assisted Endoscopic Submucosal Dissection for Colorectal Neoplasm
NCT06973083 · Robot Surgery, Endoscopic Submucosal Dissection (ESD), Colorectal Neoplasms
Not applicable Not yet open 2025-06 China
Efficacy and Safety of Cold Versus Hot Snare Polypectomy for Removal of 4-10 mm Pedunculated Colorectal Polyps
NCT06937047 · Colorectal Polyps
Not applicable Not yet open 2025-05 China
The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP
NCT06913374 · ClinicalTrials.gov ↗ · Thrombocytopenia
Phase 2/3 Not yet open 2025-05 China
One-Click Autofocus Versus Segmented Focus in Gastric Endoscopy
NCT07664813 · ClinicalTrials.gov ↗ · Stomach Neoplasms, Stomach Diseases
Not applicable Not yet open 2026-06 China
Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis
NCT06917495 · ClinicalTrials.gov ↗ · Mild Spinal Tuberculosis
Phase 2 Not yet open 2025-04 China
The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study
NCT02933229 · ClinicalTrials.gov ↗ · Helicobacter Pylori, the Operative Link on Gastric Intestinal Metaplasia, Operative Link on Gastric Intestinal Assessment
Phase 4 Not yet open 2016-10 China
Study on the Efficacy and Safety of Shouhui Tongbian Capsules in Protecting Intestine During the Perioperative Period
NCT07066059 · ClinicalTrials.gov ↗ · Perioperative Period
Phase EARLY_PHASE1 Not yet open 2025-08 China
Comparison of the Efficacy of Saccharomyces Boulardii and Rifaximin in the Treatment of Small Intestinal Bacterial Overgrowth
NCT07815548 · ClinicalTrials.gov ↗ · Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
Phase 4 Not yet open 2026-09 China
A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP
NCT05023915 · ClinicalTrials.gov ↗ · Immune Thrombocytopenia
Phase 2 Active, closed 2021-08 China
Balloon-Assisted Enteroscopic Treatment for Phytobezoar
NCT06877559 · ClinicalTrials.gov ↗ · Phytobezoar; Intestine
Observational Active, closed 2024-12 China
Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With CD
NCT06895772 · ClinicalTrials.gov ↗ · Crohn's Disease (CD)
Observational Active, closed 2024-11 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Shandong University trials

25 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Shandong University trials

42 conditions
Robot Surgery2Endoscopic Submucosal Dissection (ESD)1Colorectal Neoplasms1Colorectal Polyps1Osteoarticular Infections1Tinea Capitis1Early-Onset Neonatal Sepsis1Thrombocytopenia1Double-balloon Enteroscopy1Cancer1Stomach Neoplasms1Stomach Diseases1Infectious Diseases of Spine1Mild Spinal Tuberculosis1HELICOBACTER PYLORI INFECTIONS1COVID-19 Pneumonia1COVID-19 Pandemic1COVID-191Immune Thrombocytopenia1Colonic Polyps1Adenomatous Polyps1Adenoma Detection Rate1Chromoendoscopy1Helicobacter Pylori1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China2716

A trial with sites in more than one country appears in each of those registers.

05

Questions about Shandong University trials

How many clinical trials does Shandong University sponsor?

Shandong University is the lead sponsor of 27 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Shandong University trials recruiting?

Yes. 16 of its 27 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Shandong University testing?

Its current trials name 25 drugs and biologicals as interventions. The most frequent are Dexamethasone (3), Afatinib (1), Amoxicillin (1), Bismuth (1) and Busulfan (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.